SCHEMBL4889261

SCHEMBL4889261

C[C@@H]1C[C@H](C)CN(C(=O)c2cc(Cl)ccc2C(N)=O)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
TP53 P04637 2/20 0.46
GAA P10253 2/20 0.46
CCKBR P32239 1/20 0.45
RAB9A P51151 1/20 0.44
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 1/20 0.43
GLA P06280 1/20 0.43
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
HPGD P15428 2/20 0.42
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42
NPC1 O15118 1/20 0.40
MEN1 O00255 1/20 0.40
NSD2 O96028 1/20 0.40
MAPT P10636 1/20 0.40
NR4A1 P22736 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4889268 0.84 LMNA (0.47) LMNATP53GAACCKBRRAB9A
SCHEMBL4892518 0.83 KDM4E (0.48) LMNAGAARAB9AALDH1A1KDM4E
SCHEMBL4887092 0.81 CPS1 (0.52) RAB9AALDH1A1HPGD
SCHEMBL4887010 0.80 ALDH1A1 (0.50) LMNATP53GAACCKBRRAB9A
SCHEMBL4887023 0.76 GABRP (0.51) LMNATP53GAACCKBRALDH1A1
SCHEMBL3453484 0.74 GAA (0.68) GAAALDH1A1PLA2G1BATG4BHPGD
SCHEMBL4896886 0.74 KDM4E (0.39) LMNAGAARAB9AALDH1A1KDM4E
SCHEMBL3790275 0.73 ALDH1A1 (0.60) TP53GAAALDH1A1KDM4EGLA
SCHEMBL14087736 0.72 SMN1; SMN2 (0.50) LMNATP53CCKBRALDH1A1KDM4E
SCHEMBL10724893 0.72 PLA2G1B (0.63) GAARAB9AALDH1A1KDM4EPLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200512-A1 Hepatitis C virus polymerase inhibitors BLANEY JEFFREY MARK 2008-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200512-A1 Hepatitis C virus polymerase inhibitors SSU72, POLR2H, POLR2E LMNA 3432/4885TP53 2165/4885GAA 1626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.